Wang, Linfeng
Thawong, Naphatcha
Thorpe, Joseph
Higgins, Matthew
Ik, Mark Tan Kia
Sawaengdee, Waritta
Mahasirimongkol, Surakameth
Perdigão, João
Campino, Susana
Clark, Taane G.
Phelan, Jody E.
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council (BB/T008709/1, BB/X018156/1, BB/X018156/1, BB/X018156/1)
Thailand government, Ministry of Public Health PhD scholarship
Thailand Ministry of Public Health and the Thailand Health Systems Research Institute (HSRI 64-179, HSRI 64-179, HSRI 64-179)
Medical Research Council (MR/R020973/1, MR/R020973/1, MR/R020973/1)
Article History
Received: 5 June 2025
Accepted: 17 October 2025
First Online: 19 November 2025
Declarations
:
: This study did not involve the collection of new human or animal data. Two clinical DNA samples were obtained from TB patients who provided informed consent, as part of studies approved by the Ethics Committee for Human Research at the Faculdade de Farmácia, Universidade de Lisboa. The 68 K isolate database was compiled from publicly available sequence data sourced from the ENA. All analyses were conducted on de-identified and publicly available datasets, with all personal identifiers removed in compliance with relevant ethical standards. This work was performed in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.